Majonoside-R2 reverses social isolation stress-induced decrease in pentobarbital sleep in mice: Possible involvement of neuroactive steroids

Life Sciences

Volumn 61, Issue 4, 1997, Pages 395-402

  Huong, Nguyen Thi Thu ^a   Matsumoto, Kinzo ^a   Yamasaki, Kazuo ^b   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

CRF; GABA(A) receptors; Majonoside R2; Neurosteroids; Pentobarbitol sleep; Social isolation stress

Indexed keywords

3ALPHA,21 DIHYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; GINSENG SAPONIN; MAJONOSIDE R2; NEUROSTEROID; PENTOBARBITAL; PREGNENOLONE SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; GINSENG; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SLEEP DISORDER; SOCIAL ISOLATION;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GINSENOSIDES; HORMONE ANTAGONISTS; HYPNOTICS AND SEDATIVES; MALE; MICE; PENTOBARBITAL; PEPTIDE FRAGMENTS; PREGNENOLONE; RECEPTORS, GABA-A; SAPONINS; SLEEP; SOCIAL ISOLATION; STRESS;

ANIMALIA; PANAX GINSENG;

EID: 0030747737     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00396-2     Document Type: Article

References (24)

1. N. M. DUC, R. KASAI, K. OHTANI, A. ITO, N. T. NHAM, K. YAMASAKI and O. TANAKA, Chem. Pharm. Bull. 41 2010-2014 (1993).
2. N. T. T. HUONG, K. MATSUMOTO, K. YAMASAKI, N. M. DUC, N. T. NHAM and H. WATANABE, Pharmacol. Biochem. Behav. 53 957-963 (1996).
3. N. T. T. HUONG, K. MATSUMOTO, K. YAMASAKI, N. M. DUC, N. T. NHAM and H. WATANABE, Jpn. J. Pharmacol. 71 345-349 (1996).
4. N. T. T. HUONG, K. MATSUMOTO, K. YAMASAKI, N. M. DUC, N. T. NHAM and H. WATANABE, Pharmacol. Biochem. Behav. in press.
5. R. H. PURDY, A. L. MORROW, P. H. MOORE, JR. and S. M. PAUL, Proc. Natl. Acad. Sci. USA 88 4553-4557 (1991).
6. M. D. MAJEWSKA, Prog. Neurobiol. 38 379-395 (1992).
7. J. J. LAMBERT, D. BELELLI, C. HILL-VENNING and J. A. PETERS, TiPS 16 295-303 (1995).
8. G. BIGGIO, A. CONCAS, S. MELE and M. G. CORDA, Brain Res. Bull. 12 301-308 (1987).
9. R. D. SCHWARTZ, M. G. WEISS, R. LABARCA, P. SKOLNICK and S. M. PAUL, Brain Res. 411 151-155 (1987).
10. M. D. MAJEWSKA, J. C. BISSERBE and R. E. ESKAY, Brain Res. 339 178-182 (1985).
11. M. D. MAJEWSKA, N. L. HARRISON, R. D. SCHWARTZ, J. L. BARKER and S. M. PAUL, Science 232 1004-1007 (1986).
12. J. N. CRAWLEY, J. R. GLOWA, M. D. MAJEWSKA and S. M. PAUL, Brain Res. 398 382-385 (1986).
13. A. CONCAS, M. C. MOSTALLINO, C. PERRA, R. LENER, G. ROSCETTI, M. L. BARBACCIA, R. H. PURDY and G. BIGGIO, Br. J. Pharmacol. 118 839-846 (1996).
14. K. OJIMA, K. MATSUMOTO, M. TOHDA and H. WATANABE, Brain Res. 684 87-94 (1995).
15. K. MATSUMOTO, K. OJIMA and H. WATANABE, Brain Res. 708 1-6 (1996).
16. T. J. HALEY and W. G. MCCORMICK, Br. J. Pharmacol. 12 12-15 (1957).
17. T. KIMURA, P. A. SAUNDERS, H. S. KIM, H. M. RHEU, K. W. OH and I. K. HO, Gen. Pharmacol. 25 193-199 (1994).
18. S. M. PAUL and R. H. PURDY, FASEB J. 6 2311-2322 (1992).
19. P. ROBEL and E.-E. BAULIEU, Trend Endocrinol. Metab. 5 1-8 (1994).
20. K. T. BRITTON, G. LEE, W. VALE, J. RIVIER and G. F. KOOB, Brain Res. 369 303-306 (1986).
21. T. IMAKI, T. SHIBASAKI, A. MASUDA, K. SHIZUME and N. LING, Brain Res. 383 323-326 (1986).
22. A. J. DUNN and C. W. BERRIDGE, Brain Res. Rev. 15 71-100 (1990).
23. T. SHIBASAKI, N. YAMAUCHI, M. HOTTA, T. IMAKI, T. ODA, N. LING and H. DEMURA, Brain Res. 554 352-354 (1991).
24. K. T. BRITTON, S. MCLEOD, G. F. KOOB and R. HAUGER, Pharmacol. Biochem. Behav. 41 399-403 (1992).